Skip to main content
Caplight Logo









Spearhead Bio

Spearhead Bio

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://spearhead.bio/

Last Round

Seed

Jan 29, 2026

Total Funding Raised

$4.31M

Company Overview

Spearhead Bio operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Seed round in January 2026.

Spearhead Bio is a biotechnology company that develops a native genome engineering platform to enhance the efficiency of crop genome engineering.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Spearhead Bio Comparables

Compare Spearhead Bio with similar companies based on industry and business-model similarity.

Spearhead Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hudson River Biotechnology
76%
Solis Agrosciences
72%
Verinomics
71%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Spearhead Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 29, 2026
GrantJul 14, 2025
SeedMay 13, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Spearhead Bio Investors

Notable investors and investment history

Spearhead Bio investors
InvestorRounds
Danforth Technology CompanySeed
BioGenerator VenturesSeed
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 14, 2025

    $305K round from the National Science Foundation

Book a demo to see all signals

For institutional investors. Book with your work email.

Spearhead Bio Filings

Explore SEC and related filing metadata, where available.

Spearhead Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Spearhead Bio's valuation, stock price, and market status.

Is Spearhead Bio a public or private company?

Spearhead Bio is a private company.

What is the current stock price of Spearhead Bio?

Spearhead Bio is a private company, so its shares have no public market price. Caplight tracks Spearhead Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Spearhead Bio worth (valuation)?

Valuation information for Spearhead Bio is not publicly available.

Can I buy Spearhead Bio stock?

Spearhead Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Spearhead Bio's last funding round?

Spearhead Bio's most recent funding round was Seed on January 29, 2026.

Who are the main investors in Spearhead Bio?

Key investors in Spearhead Bio include Danforth Technology Company.

Will Spearhead Bio IPO soon?

No public IPO plans have been announced for Spearhead Bio.

How can I track Spearhead Bio secondary market activity?

Caplight tracks bids, offers, and trades in Spearhead Bio's shares on secondary markets.

Firmographic Details

HeadquartersSaint Louis, Michigan
Year Founded2025
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?